Collateral damage: toxic effects of targeted antiangiogenic therapies in ovarian cancer
RL Stone, AK Sood, RL Coleman - The lancet oncology, 2010 - thelancet.com
… therapy for ovarian cancer and its … ovarian cancer. The inherent hope with targeted therapies,
such as bevacizumab, is to achieve an antitumour response, while largely sparing damage …
such as bevacizumab, is to achieve an antitumour response, while largely sparing damage …
The “collateral damage” of the war on COVID-19: impact of the pandemic on the care of epithelial ovarian cancer
L Goenka, A Anandaradje, T Nakka, S Kayal… - Medical oncology, 2021 - Springer
The covid-19 pandemic has impacted the management of non-covid-19 illnesses. Epithelial
ovarian cancer (EOC) requires long-duration multidisciplinary treatment. Teleconsultation …
ovarian cancer (EOC) requires long-duration multidisciplinary treatment. Teleconsultation …
Collateral damage of COVID-19 pandemic: The impact on a gynecologic surgery department
J Piketty, M Carbonnel, R Murtada, A Revaux… - Journal of Gynecology …, 2022 - Elsevier
… These included six cases of endometrial cancer, 5 cases of ovarian cancer and 4 cases
of breast cancer that were treated by hormonal therapy or chemotherapy. Four conization …
of breast cancer that were treated by hormonal therapy or chemotherapy. Four conization …
Collateral damage intended—cancer-associated fibroblasts and vasculature are potential targets in cancer therapy
A Cavaco, M Rezaei, S Niland, JA Eble - International Journal of …, 2017 - mdpi.com
… miR-27b binds to the 3′-untranslated region (3′-UTR) of VE-cadherin mRNA and
inhibits ovarian cancer cell-mediated VM through suppression of VE-cadherin expression [320]. …
inhibits ovarian cancer cell-mediated VM through suppression of VE-cadherin expression [320]. …
Collateral Damage Associated with
AS Tsao, DJ Stewart - Medical care of cancer patients, 2009 - books.google.com
… Melphalan has been used in ovarian cancer and is associated with a marked increase in the
risk of … in 32251 women treated for ovarian cancer. 109 In breast cancer patients, melphalan …
risk of … in 32251 women treated for ovarian cancer. 109 In breast cancer patients, melphalan …
Mechanisms of drug resistance in ovarian cancer and associated gene targets
KL Alatise, S Gardner, A Alexander-Bryant - Cancers, 2022 - mdpi.com
… ovarian cancer being the most lethal. One of the hallmark characteristics of ovarian cancer is
… therapies, from drug efflux proteins to ovarian cancer stem cells. The review also addresses …
… therapies, from drug efflux proteins to ovarian cancer stem cells. The review also addresses …
Photoimmunotherapy of ovarian cancer: a unique niche in the management of advanced disease
… PIT compensates for this potential for collateral damage through antibody-mediated tumor-specific
accumulation of PSs and spatiotemporal control of light irradiation and PS activation. …
accumulation of PSs and spatiotemporal control of light irradiation and PS activation. …
[HTML][HTML] Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic
… cancers, with >30% reduction in survival at 6 months and >17% reduction in survival at 3
months for patients with stage 2 or 3 cancers of the bladder, lung, oesophagus, ovary, liver, …
months for patients with stage 2 or 3 cancers of the bladder, lung, oesophagus, ovary, liver, …
Treatment options in the management of ovarian cancer
Y Kikuchi, T Kita, M Takano, K Kudoh… - Expert Opinion on …, 2005 - Taylor & Francis
… eradication of disseminated cancers. Ovarian cancer is the fifth leading cause of cancer death
in … Although the collateral damage inflicted on the dividing bone marrow progenitors, gut …
in … Although the collateral damage inflicted on the dividing bone marrow progenitors, gut …
Collateral damage: insights into bacterial mechanisms that predispose host cells to cancer
… As part of their infection cycle, many bacteria secrete toxins that cause DNA damage in host
cells. Genomic instability is a hallmark of cancer development because DNA damage may …
cells. Genomic instability is a hallmark of cancer development because DNA damage may …
相关搜索
- epithelial ovarian cancer collateral damage
- drug resistance in ovarian cancer
- treatment of ovarian cancer
- ovarian cancer management
- chemoresistance in ovarian cancer
- ovarian cancer antiangiogenic drugs
- ovarian cancer photodynamic therapy
- covid 19 pandemic collateral damage
- ovarian cancer anti-angiogenic agents
- vasculogenic mimicry in ovarian cancer
- epigenetic modifications in ovarian cancer
- chemotherapy resistance in epithelial ovarian cancer
- peritoneal metastasis of epithelial ovarian cancer
- ovarian cancer in vivo
- infrared photoimmunotherapy ovarian cancer model
- women with ovarian cancer